-
OHI completes first case in SUPPORT II research trial
Read more: OHI completes first case in SUPPORT II research trialOklahoma Heart Institute (OHI) was the first facility in the country to use the next-generation Supira percutaneous left ventricular assist device (pVAD) as part of the SUPPORT II research trial. What is the Supira pVAD? The Supira pVAD helps the left ventricle pump blood through the heart during high-risk stenting (HRPCI) used while treating blockages…
Latest News
- From ECMO Patient to Occupational Therapist: Kelsey Carter’s Remarkable Recovery
- Oklahoma Heart Institute TAVR program ranked #19 in nation and #1 in Oklahoma by U.S. News & World Report
- Oklahoma Heart Institute Leads Nation in Groundbreaking Heart Research and First-in-U.S. Device Trial
- OHI completes first case in SUPPORT II research trial
- “They save lives”: Mother survives spontaneous coronary artery dissection thanks to OHI providers’ quick action